Ophthalmology Times - Ophthalmology news, articles, and events
Nov 4, 2024 · AAO 2024: The role of MIGS in earlier intervention and safer techniques. AAO 2024: New data and studies in glaucoma. AAO 2024: Office based surgery. AAO 2024: MIGS: Devices and incisional techniques. AAO 2024: Energy drinks and central retinal vein occlusions. This Week in Ophthalmology: Week of October 19, 2024.
Breaking down the dorzolamide shortage - Ophthalmology Times
Aug 9, 2019 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in a positive ...
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
Aug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
Physicians sort out pros and cons of several new IOLs on the market
Nov 12, 2021 · The 2 newest multifocal IOLs—AcrySof IQ PanOptix (Alcon) and Tecnis Synergy (Johnson + Johnson Vision)—almost guarantee a broader range of vision than EDoF IOLs but not the avoidance of photic phenomena, Sood said. The PanOptix is a trifocal lens with negative spherical aberration on its anterior surface that has diffractive rings in the ...
Myths and misconceptions about autologous serum for dry eye
Jun 22, 2020 · Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.
Dry eye paradise: FDA green-lights Miebo as first and only eye …
Jun 21, 2023 · According to the companies, perfluorohexyloctane ophthalmic solution is the first and only FDA-approved treatment for DED that directly targets tear evaporation instead of tear formation. Formerly known as NOV03, the drug was developed by Novaliq, and Bausch + Lomb attained exclusive licensing in the United States and Canada in 2019. 12.
Fluorometholone acetate: More benefit than meets the eye
Dec 11, 2019 · The ability of a drug to penetrate into the ocular tissues is key to controlling inflammation. “All fluorometholones are not the same,” said Beeran Meghpara, MD, and with good reason.Fluorometholone is the active steroid in formulations used to treat ocular inflammation- however, it is what doesn’t meet the eye that makes the difference, i.e., the vehicle.
Identifying, managing dysphotopsia after cataract surgery
Apr 25, 2014 · Boston — Following cataract surgery, patients can present with a variety of visual complaints-i.e., dysphotopsias, aberrant optical phenomena that interfere with vision after IOL implantation. Positive dysphotopsias include rainbows, streaks, crescents, rings, halos, and veiling glare, haze, and fog. Negative dysphotopsias are relative and ...
Advancements in ophthalmology: A comprehensive look at the …
Dec 12, 2023 · It’s safe to say 2024 will have to work extra hard to top the year 2023. Overall, 2023 emerges as a landmark year in the realm of ophthalmology, marked by an extraordinary 12 FDA approvals. The approval of Apellis' pegcetacoplan injection for geographic atrophy marked a significant milestone, addressing an unmet need for GA patients.
FDA approves pilocarpine hydrochloride ophthalmic solution for ...
Oct 18, 2023 · Orasis Pharmaceuticals announced the FDA has approved pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi) for the treatment of presbyopia in adults. The company announced it expects to have pilocarpine hydrochloride ophthalmic solution commercially available in the U.S. in the first half of 2024 …